Cargando…
Safety and efficacy of ex vivo expanded CD34(+) stem cells in murine and primate models
BACKGROUND: Hematopoietic stem cell (HSC) transplantation has been widely applied to the treatment of malignant blood diseases. However, limited number of functional HSCs hinders successful transplantation. The purpose of our current study is to develop a new and cost-efficient medium formulation th...
Autores principales: | Zhang, Yu, Shen, Bin, Guan, Xin, Qin, Meng, Ren, Zhihua, Ma, Yupo, Dai, Wei, Ding, Xinxin, Jiang, Yongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567473/ https://www.ncbi.nlm.nih.gov/pubmed/31196160 http://dx.doi.org/10.1186/s13287-019-1275-0 |
Ejemplares similares
-
Ex-vivo expansion of nonhuman primate CD34(+) cells by stem cell factor Sall4B
por: Shen, Bin, et al.
Publicado: (2016) -
Large‐Scale Ex Vivo Generation of Human Red Blood Cells from Cord Blood CD34(+) Cells
por: Zhang, Yu, et al.
Publicado: (2017) -
Large-scale ex vivo generation of human neutrophils from cord blood CD34(+) cells
por: Jie, Zhenwang, et al.
Publicado: (2017) -
An effective ex-vivo approach for inducing endothelial progenitor cells from umbilical cord blood CD34(+) cells
por: Qin, Meng, et al.
Publicado: (2017) -
Safety and Efficacy of Megakaryocytes Induced from Hematopoietic Stem Cells in Murine and Nonhuman Primate Models
por: Guan, Xin, et al.
Publicado: (2016)